Due to its synergistic effects and reduced side effects,combination therapy has become an important strategy for treating complex diseases.In traditional Chinese medicine(TCM),the“monarch,minister,assistant,envoy”co...Due to its synergistic effects and reduced side effects,combination therapy has become an important strategy for treating complex diseases.In traditional Chinese medicine(TCM),the“monarch,minister,assistant,envoy”compatibilities theory provides a systematic framework for drug compatibility and has guided the formation of a large number of classic formulas.However,due to the complex compositions and diverse mechanisms of action of TCM,it is difficult to comprehensively reveal its potential synergistic patterns using traditional methods.Synergistic prediction based on molecular compatibility theory provides new ideas for identifying combinations of active compounds in TCM.Compared to resource-intensive traditional experimental methods,artificial intelligence possesses the ability to mine synergistic patterns from multi-omics and structural data,providing an efficient means for modeling and optimizing TCM combinations.This paper systematically reviews the application progress of AI in the synergistic prediction of TCM active compounds and explores the challenges and prospects of its application in modeling combination relationships,thereby contributing to the modernization of TCM theory and methodological innovation.展开更多
This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasiz...This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasizes recent research developments,including intelligent design,prediction of mechanisms of action,and precise application of TCM compound prescriptions.The integration of multi-omics data,deep learning algorithms,and knowledge graph technologies has established novel technical avenues for the modernization research of TCM.This study systematically analyzes the advantages and challenges associated with AI technologies in the research of TCM compound prescriptions,highlighting issues such as data heterogeneity,limited interpretability of AI models,and the absence of standardized procedures.Furthermore,this article examines the prospective developmental trajectories within this field,highlighting the importance of synergistic collaboration between AI and traditional pharmacology to improve the clinical applicability and effectiveness of TCM.The objective is to offer valuable insights into the modernization of TCM driven by AI and to stimulate further research in this area.展开更多
Xiongdankaiming tablet (XDKMT), a well-known compound in traditional Chinese medicine, is widely used for the treatment of acute iridocyclitis and primary open-angle glaucoma. In this paper, accurate and reliable meth...Xiongdankaiming tablet (XDKMT), a well-known compound in traditional Chinese medicine, is widely used for the treatment of acute iridocyclitis and primary open-angle glaucoma. In this paper, accurate and reliable methods were developed for the identification of 20 constituents using high-performance liquid chromatography with photodiode array and electron spray ionization-mass spectrometry (HPLC-PDA/ESI-MSn ), and determination of nine of the constituents (chlorogenic acid, gentiopicroside, isochlorogenic acid B, diosmetin-7-O-β-D-glucopyranoside, apigenin, diosmetin, tauroursodeoxycholic acid, acacetin, and taurochenodeoxycholic acid) was developed using HPLC with ultraviolet absorption detector and evaporative light scattering detector (HPLC-UV/ELSD) for the first time. The best results were obtained on a Zorbax SB-C18 column with gradient elution using water (0.1% formic acid) (A) and methanol (0.1% formic acid) (B) at a flow rate of 0.7 ml/min. Tauroursodeoxycholic acid and taurochenodeoxycholic acid, owing to their low UV absorption, were detected by ELSD. The other seven compounds were analyzed by HPLC-UV with variable wavelengths. The calibration curves of all nine constituents showed good linear regression (R2 >0.9996) within the linearity ranges. The limits of detection and quantification were in the ranges of 0.0460-9.90 μg/ml and 0.115-24.8 μg/ml, respectively. The accuracy, in terms of recovery, varied from 95.3% to 104.9% with relative standard deviations (RSDs) less than 4.4%. Precision (with the intra- and inter-day variations less than 4.4%) was also suitable for its intended use. The developed method was successfully applied for the analysis of major components in XDKMT, which provides an appropriate method for the quality control of XDKMT.展开更多
As an important representative of the modernization of the Chinese medicine industry,traditional Chinese medicine(TCM)compound preparations are an indispensable part of the development of TCM.The complex ingredients a...As an important representative of the modernization of the Chinese medicine industry,traditional Chinese medicine(TCM)compound preparations are an indispensable part of the development of TCM.The complex ingredients and unclear action mechanism of TCM compound preparations restrict the development of TCM.In line with this problem,the modern TCM research has made extensive remarkable achievements.From the single indicator in the past to multiple indicator,the research on the combination of TCM fingerprints and pharmacodynamics also has made great progress.The introduction of quality evaluation methods such as the"quantitative analysis of multi-components by a single marker","dose-effect"indicator,"Bioactive Equivalent Combinatorial Components"(BECCs)and TCM quality markers have brought new ideas for quality control of TCM compound preparations.展开更多
Objective:To evaluate the efficacy and safety of different Chinese herbal compounds combined with Entecavir in the treatment of hepatitis B cirrhosis during the compensatory period by using mesh meta-analysis.Methods:...Objective:To evaluate the efficacy and safety of different Chinese herbal compounds combined with Entecavir in the treatment of hepatitis B cirrhosis during the compensatory period by using mesh meta-analysis.Methods:PubMed,CNKI,Wanfang and VIP databases were searched by computer,and the retrieval time was from the establishment of each database to October 5,2022.According to inclusion and exclusion criteria,literature search was conducted independently by two researchers.RevMan5.4.1 software provided by Cochrane was used for evaluation,and Stata16.0 software was used for statistical analysis.Results:A total of 34 RCTs were included,involving 16 TCM compounds and 1543 patients.The results of network meta-analysis showed that ALT indexes of liver function were listed as Yiqi Jiedu Tongluo Method>Luoshugan Tablet>Anluo Huaxian Wan>Qishenrugan Capsule>Qingganhuaji Decoction>Ganshuang Granules>Compound Biejia Rugan Tablet>Rougan Sanjie Decoction>Shugan Jianpi Decoction>Shenqi Fuzheng Huayu Decoction>Peituhua Decoction>Shugan Jianpi Huoxu prescription>Rhubarb Zhezhan Capsule combined with Entecavir treatment respectively;The order of HA index of liver fibrosis was Heluo Shugan Tablet>Shugan Jianpi Huoxui prescription>Anluo Huaxian Wan>Compound Biejia Ruangan Tablet>Rougan Sanjie Decoction>Ganshuang Granules>Danji Huoxui Decoction>Yiqi Jiedu Tongluo Method>Rhubarb Zhezhe Capsule>Fuzheng Huayu Table>Shugan Jianpi Decoction>Rougan Huayu Decoction>Peitu Huayu Decoction>Qingganhuaji Prescription>Shenqi Fuzheng Huayu prescription combined with Entecavir respectively;In order of adverse reactions from best to worst,Shuganjianpi Decoction,Qishenrugangan Capsule,Ganshuang Granules,Peituhuazhi Decoction,compound Biejiruganpian,and He Shugan Pian combined with entecavir,respectively;The effective rate of treatment was listed as Ganshuang Granules>Compound Biejia Ruangan Tablets>uoshugan Tablets>Rougansanjie Decoction>Rhubarb Zhezhe Capsules>Yiqi Jiedu Tongluo Method>Qingganhuaji prescription>Anluo Huaxia Wan>Shugan Jianpi Decoction>Fuzheng Huayu tablets>Peituhuazhi Decoction>Shenqi Fuzheng Huayu prescription combined with Entecavir respectively.Conclusion:Entecavir combined with supplementing qi and detoxifying and dredging collages is the best method to recover ALT index of liver function during the compensation period for hepatitis B cirrhosis;Entecavir combination and Luoshugan tablet were the best treatment for HA index of hepatic fibrosis;Entecavir combined with Shuganjianpi Decoction was the best treatment for adverse reactions;The best treatment efficiency was Entecavir combined with Ganshuang granules.展开更多
目的通过评价中药复方防治胃癌前病变(PLGC)动物实验研究的方法学质量及报告质量,分析实验过程中的偏倚风险及研究报告的不足,为提高中药复方防治PLGC动物实验研究质量提供参考。方法计算机检索中国知识资源总库(CNKI)、万方数据知识服...目的通过评价中药复方防治胃癌前病变(PLGC)动物实验研究的方法学质量及报告质量,分析实验过程中的偏倚风险及研究报告的不足,为提高中药复方防治PLGC动物实验研究质量提供参考。方法计算机检索中国知识资源总库(CNKI)、万方数据知识服务平台(WanfangData)、中文科技期刊数据库(VIP)、中国生物医学文献数据库(CBM)、PubMed、Cochrane Library、Web of Science和Embase数据库2014年1月1日-2024年2月23日发表的关于中药复方防治PLGC动物实验文献,采用SYRCLE工具和ARRIVE2.0指南对纳入文献进行评分并计算各条目“低风险”符合率。结果共纳入文献213篇,其中中文文献189篇、英文文献24篇。SYRCLE工具评分为(12.86±1.29)分,“低风险”符合率为32.79%。ARRIVE2.0指南必备条目评分为(24.15±2.80)分,“低风险”符合率为49.08%;推荐条目评分为(11.28±3.40)分,“低风险”符合率为30.27%。SYRCLE工具评价中,144项(67.61%)研究未详细阐述分配序列产生的方法,所有研究均未描述分配隐藏充分与否及实施偏倚过程中的盲法,7项(3.29%)研究描述对结果评价者施盲。ARRIVE2.0指南中,所有研究均未报告样本量的确定方法、均未提供用于确定样本量的结局指标及实验方案注册声明,51项(23.94%)研究明确提出PLGC造模成功标准,66项(30.96%)研究提供所使用统计方法的详细信息,29项(13.62%)研究提供完整的伦理声明,22项(10.33%)报告了利益冲突。结论2014-2024年发表的中药复方防治PLGC动物实验文献方法学质量及报告质量存在较多问题,尤其是在实验过程中随机盲法策略的实施、样本量计算细节及纳入排除标准报告等方面存在缺陷,建议今后研究参考SYRCLE工具及ARRIVE2.0指南清单,以优化研究方案和报告,提高PLGC动物实验研究结果的可信度与规范性。展开更多
基金supported by the National Key Research and Development Program of China(No.2024YFC3506900)Science and Technology Program of Tianjin(No.24ZXZSSS00460)Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines(No.24ZXZKSY00010)。
文摘Due to its synergistic effects and reduced side effects,combination therapy has become an important strategy for treating complex diseases.In traditional Chinese medicine(TCM),the“monarch,minister,assistant,envoy”compatibilities theory provides a systematic framework for drug compatibility and has guided the formation of a large number of classic formulas.However,due to the complex compositions and diverse mechanisms of action of TCM,it is difficult to comprehensively reveal its potential synergistic patterns using traditional methods.Synergistic prediction based on molecular compatibility theory provides new ideas for identifying combinations of active compounds in TCM.Compared to resource-intensive traditional experimental methods,artificial intelligence possesses the ability to mine synergistic patterns from multi-omics and structural data,providing an efficient means for modeling and optimizing TCM combinations.This paper systematically reviews the application progress of AI in the synergistic prediction of TCM active compounds and explores the challenges and prospects of its application in modeling combination relationships,thereby contributing to the modernization of TCM theory and methodological innovation.
文摘This article provides a comprehensive review of the advancements in the application of artificial intelligence(AI)technology in the modernization of traditional Chinese medicine(TCM)compound prescriptions,and emphasizes recent research developments,including intelligent design,prediction of mechanisms of action,and precise application of TCM compound prescriptions.The integration of multi-omics data,deep learning algorithms,and knowledge graph technologies has established novel technical avenues for the modernization research of TCM.This study systematically analyzes the advantages and challenges associated with AI technologies in the research of TCM compound prescriptions,highlighting issues such as data heterogeneity,limited interpretability of AI models,and the absence of standardized procedures.Furthermore,this article examines the prospective developmental trajectories within this field,highlighting the importance of synergistic collaboration between AI and traditional pharmacology to improve the clinical applicability and effectiveness of TCM.The objective is to offer valuable insights into the modernization of TCM driven by AI and to stimulate further research in this area.
文摘化疗后周围神经病变(chemotherapy-induced peripheral neuropathy,CIPN)是癌症患者接受化疗过程中常见的严重并发症,严重影响患者的生活质量和治疗依从性。近年来,中医在缓解CIPN症状方面展现出独特优势,针灸与中药复方在减轻疼痛、改善感觉障碍以及促进神经再生等方面展现出良好潜力。文章通过系统检索PubMed、Web of Science和CNKI等数据库,综述了近五年中医治疗CIPN的研究进展,重点探讨其作用机制、疗效评价及多学科融合的研究方向。研究表明,中医治疗通过抗炎、抗氧化、调节神经生长因子及肠道菌群等多途径、多靶点机制显著缓解CIPN症状。此外,神经影像学和分子生物学技术的应用为揭示针灸和中药的作用机制提供了新的视角。尽管中医治疗在安全性和患者接受度方面具有优势,但研究设计质量不足、样本量较小及中药制剂标准化不足等问题限制了其国际化推广。文章提出构建“中医-现代科学”整合模型,探索肠-脑轴调节机制,并推动中药制剂的标准化和疗效评价体系的完善,为CIPN的治疗策略优化及中医治疗的国际化应用提供科学依据。
基金Project (No. 2011FZA7005) supported by the Fundamental Research Funds for the Central Universities of China
文摘Xiongdankaiming tablet (XDKMT), a well-known compound in traditional Chinese medicine, is widely used for the treatment of acute iridocyclitis and primary open-angle glaucoma. In this paper, accurate and reliable methods were developed for the identification of 20 constituents using high-performance liquid chromatography with photodiode array and electron spray ionization-mass spectrometry (HPLC-PDA/ESI-MSn ), and determination of nine of the constituents (chlorogenic acid, gentiopicroside, isochlorogenic acid B, diosmetin-7-O-β-D-glucopyranoside, apigenin, diosmetin, tauroursodeoxycholic acid, acacetin, and taurochenodeoxycholic acid) was developed using HPLC with ultraviolet absorption detector and evaporative light scattering detector (HPLC-UV/ELSD) for the first time. The best results were obtained on a Zorbax SB-C18 column with gradient elution using water (0.1% formic acid) (A) and methanol (0.1% formic acid) (B) at a flow rate of 0.7 ml/min. Tauroursodeoxycholic acid and taurochenodeoxycholic acid, owing to their low UV absorption, were detected by ELSD. The other seven compounds were analyzed by HPLC-UV with variable wavelengths. The calibration curves of all nine constituents showed good linear regression (R2 >0.9996) within the linearity ranges. The limits of detection and quantification were in the ranges of 0.0460-9.90 μg/ml and 0.115-24.8 μg/ml, respectively. The accuracy, in terms of recovery, varied from 95.3% to 104.9% with relative standard deviations (RSDs) less than 4.4%. Precision (with the intra- and inter-day variations less than 4.4%) was also suitable for its intended use. The developed method was successfully applied for the analysis of major components in XDKMT, which provides an appropriate method for the quality control of XDKMT.
基金Supported by Project of National Natural Science Foundation of China(81560691)Special Fund Project for Innovation Driven Development of Guangxi(Gui Ke AA17202046)+8 种基金Program of Scientific Research Third-level Laboratory"Chinese(Zhuang)Medicine Chemical and Quality Analysis Laboratory"of State Administration of Traditional Chinese Medicine(Guo Zhong Yi Yao Fa 2009[21])Program of Key Laboratory for Purification and Quality Analysis of TCM Extraction in Guangxi Universities(Gui Jiao Ke Yan[2014]No.6)Program of Collaborative Innovation Center of Zhuang and Yao Medicine(Gui Jiao Ke Yan:2013 No.20)Program of Key Laboratory of Zhuang and Yao Medicine[Gui Ke Ji Zi:2014 No.32]Bagui Scholar Program of Key Discipline of Guangxi"Study on Innovation Theory and Efficacy of Traditional Chinese Medicine"[Gui Ke Zheng Zi:2013 No.25]High-level Talent Team Cultivation Program of"Qihuang Project"of Guangxi University of Chinese Medicine(2018002)Open Program for Construction of TCM Pharmacy Doctor Station in Guangxi University of Chinese Medicine(201410-06)High Level Innovation Team and Excellent Scholar Program of Guangxi Universities(Gui Jiao Shi Fan 2019 No.52)Guangxi One Thousand Young and Middle-aged College and University Backbone Teachers Cultivation Program(Gui Jiao Ren2019 No.5).
文摘As an important representative of the modernization of the Chinese medicine industry,traditional Chinese medicine(TCM)compound preparations are an indispensable part of the development of TCM.The complex ingredients and unclear action mechanism of TCM compound preparations restrict the development of TCM.In line with this problem,the modern TCM research has made extensive remarkable achievements.From the single indicator in the past to multiple indicator,the research on the combination of TCM fingerprints and pharmacodynamics also has made great progress.The introduction of quality evaluation methods such as the"quantitative analysis of multi-components by a single marker","dose-effect"indicator,"Bioactive Equivalent Combinatorial Components"(BECCs)and TCM quality markers have brought new ideas for quality control of TCM compound preparations.
基金National Natural Science Foundation Project(82204755,81960751,81960761)Guangxi Natural Science Foundation Youth Fund Project(2020GXNSFBA297094)+2 种基金Guangxi young and middle-aged teachers basic ability improvement project(2022KY1667)Guangxi University of Traditional Chinese Medicine Sainz New School of Medicine research project(2022MS008,2022QJ001)Innovation and Entrepreneurship Training Program for College Students of Guangxi University of Traditional Chinese Medicine(National Level),Project Number:202213643002.
文摘Objective:To evaluate the efficacy and safety of different Chinese herbal compounds combined with Entecavir in the treatment of hepatitis B cirrhosis during the compensatory period by using mesh meta-analysis.Methods:PubMed,CNKI,Wanfang and VIP databases were searched by computer,and the retrieval time was from the establishment of each database to October 5,2022.According to inclusion and exclusion criteria,literature search was conducted independently by two researchers.RevMan5.4.1 software provided by Cochrane was used for evaluation,and Stata16.0 software was used for statistical analysis.Results:A total of 34 RCTs were included,involving 16 TCM compounds and 1543 patients.The results of network meta-analysis showed that ALT indexes of liver function were listed as Yiqi Jiedu Tongluo Method>Luoshugan Tablet>Anluo Huaxian Wan>Qishenrugan Capsule>Qingganhuaji Decoction>Ganshuang Granules>Compound Biejia Rugan Tablet>Rougan Sanjie Decoction>Shugan Jianpi Decoction>Shenqi Fuzheng Huayu Decoction>Peituhua Decoction>Shugan Jianpi Huoxu prescription>Rhubarb Zhezhan Capsule combined with Entecavir treatment respectively;The order of HA index of liver fibrosis was Heluo Shugan Tablet>Shugan Jianpi Huoxui prescription>Anluo Huaxian Wan>Compound Biejia Ruangan Tablet>Rougan Sanjie Decoction>Ganshuang Granules>Danji Huoxui Decoction>Yiqi Jiedu Tongluo Method>Rhubarb Zhezhe Capsule>Fuzheng Huayu Table>Shugan Jianpi Decoction>Rougan Huayu Decoction>Peitu Huayu Decoction>Qingganhuaji Prescription>Shenqi Fuzheng Huayu prescription combined with Entecavir respectively;In order of adverse reactions from best to worst,Shuganjianpi Decoction,Qishenrugangan Capsule,Ganshuang Granules,Peituhuazhi Decoction,compound Biejiruganpian,and He Shugan Pian combined with entecavir,respectively;The effective rate of treatment was listed as Ganshuang Granules>Compound Biejia Ruangan Tablets>uoshugan Tablets>Rougansanjie Decoction>Rhubarb Zhezhe Capsules>Yiqi Jiedu Tongluo Method>Qingganhuaji prescription>Anluo Huaxia Wan>Shugan Jianpi Decoction>Fuzheng Huayu tablets>Peituhuazhi Decoction>Shenqi Fuzheng Huayu prescription combined with Entecavir respectively.Conclusion:Entecavir combined with supplementing qi and detoxifying and dredging collages is the best method to recover ALT index of liver function during the compensation period for hepatitis B cirrhosis;Entecavir combination and Luoshugan tablet were the best treatment for HA index of hepatic fibrosis;Entecavir combined with Shuganjianpi Decoction was the best treatment for adverse reactions;The best treatment efficiency was Entecavir combined with Ganshuang granules.
文摘目的通过评价中药复方防治胃癌前病变(PLGC)动物实验研究的方法学质量及报告质量,分析实验过程中的偏倚风险及研究报告的不足,为提高中药复方防治PLGC动物实验研究质量提供参考。方法计算机检索中国知识资源总库(CNKI)、万方数据知识服务平台(WanfangData)、中文科技期刊数据库(VIP)、中国生物医学文献数据库(CBM)、PubMed、Cochrane Library、Web of Science和Embase数据库2014年1月1日-2024年2月23日发表的关于中药复方防治PLGC动物实验文献,采用SYRCLE工具和ARRIVE2.0指南对纳入文献进行评分并计算各条目“低风险”符合率。结果共纳入文献213篇,其中中文文献189篇、英文文献24篇。SYRCLE工具评分为(12.86±1.29)分,“低风险”符合率为32.79%。ARRIVE2.0指南必备条目评分为(24.15±2.80)分,“低风险”符合率为49.08%;推荐条目评分为(11.28±3.40)分,“低风险”符合率为30.27%。SYRCLE工具评价中,144项(67.61%)研究未详细阐述分配序列产生的方法,所有研究均未描述分配隐藏充分与否及实施偏倚过程中的盲法,7项(3.29%)研究描述对结果评价者施盲。ARRIVE2.0指南中,所有研究均未报告样本量的确定方法、均未提供用于确定样本量的结局指标及实验方案注册声明,51项(23.94%)研究明确提出PLGC造模成功标准,66项(30.96%)研究提供所使用统计方法的详细信息,29项(13.62%)研究提供完整的伦理声明,22项(10.33%)报告了利益冲突。结论2014-2024年发表的中药复方防治PLGC动物实验文献方法学质量及报告质量存在较多问题,尤其是在实验过程中随机盲法策略的实施、样本量计算细节及纳入排除标准报告等方面存在缺陷,建议今后研究参考SYRCLE工具及ARRIVE2.0指南清单,以优化研究方案和报告,提高PLGC动物实验研究结果的可信度与规范性。
